Glucerna

DIETARY_SUPPLEMENT5 trials

Sponsors

Vegenat, S.A., Shanghai 10th People's Hospital, PHJ van der Voort, Eyal Leibovitz, Hospital Universitario San Ignacio

Conditions

DiabeticsDisorder of Glucose RegulationHyperglycemiaHypoglycemiaMalnutrition; DiabetesMetabolic SyndromeObesityObesity & Overweight

Phase 3

Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional Care

Eyal LeibovitzHypoglycemia, Malnutrition; Diabetes

Start: 2019-07-01End: 2023-12-31Target: 500Updated: 2021-04-23

Unknown Phase

Clinical Evaluation of a Specific Enteral Diet for Diabetics

Vegenat, S.A.Diabetics, Hyperglycemia, Metabolic Syndrome

Start: 2009-09-30End: 2015-05-31Updated: 2014-12-10

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure

CompletedNCT02118389

Shanghai 10th People's HospitalObesity

Start: 2013-10-31End: 2013-12-31Updated: 2014-04-21

The Glycaemic Effects of Glucerna® in Critically Ill Patients.

CompletedNCT02594865

PHJ van der VoortDisorder of Glucose Regulation

Start: 2015-09-30End: 2016-06-30Updated: 2016-06-27

Influence of the Use of Specific Nutritional Formulas on Time in Range in Patients With Type 2 Diabetes

Not yet recruitingNCT07666581

Hospital Universitario San IgnacioObesity & Overweight, Time in Range, Type 2 Diabetes

Start: 2026-08-01End: 2028-12-01Target: 198Updated: 2026-06-24